Mark H Ravich is Director of ROCKWELL MEDICAL, INC.. Currently has a direct ownership of 121,429 shares of RMTI, which is worth approximately $296,286. The most recent transaction as insider was on Nov 15, 2024, when has been sold 10,000 shares (Common Stock) at a price of $2.4 per share, resulting in proceeds of $24,000. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 121K
11.58% 3M change
59.97% 12M change
Total Value Held $296,286

MARK H RAVICH Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 15 2024
SELL
Open market or private sale
$24,000 $2.4 p/Share
10,000 Reduced 7.61%
121,429 Common Stock
May 21 2024
BUY
Grant, award, or other acquisition
-
36,111 Added 24.91%
108,831 Common Stock
May 23 2023
BUY
Grant, award, or other acquisition
-
24,715 Added 7.53%
303,319 Common Stock
Jun 07 2022
BUY
Grant, award, or other acquisition
-
25,000 Added 8.23%
278,604 Common Stock
Jun 17 2021
BUY
Grant, award, or other acquisition
-
50,000 Added 16.47%
253,604 Common Stock
MHR

Mark H Ravich

Director
Hackensack, NJ

Track Institutional and Insider Activities on RMTI

Follow ROCKWELL MEDICAL, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RMTI shares.

Notify only if

Insider Trading

Get notified when an Rockwell Medical, Inc. insider buys or sells RMTI shares.

Notify only if

News

Receive news related to ROCKWELL MEDICAL, INC.

Track Activities on RMTI